Si prevede che il mercato della proteomica crescerà al 15,15% di CAGR dal 2023 al 2029. Si prevede che raggiungerà oltre 74,27 miliardi di USD entro il 2029 dai 21,79 miliardi di USD del 2022.
Un proteoma è l'intero set di proteine che un sistema o un organismo genera. Può cambiare a seconda del tempo, delle specifiche e degli stress a cui un organismo è sottoposto. La proteomica è definita come il ramo della biotecnologia che si occupa di utilizzare la biologia molecolare, la biochimica e le tecniche genetiche per esaminare la struttura, la funzione e le interazioni delle proteine prodotte dai geni di una cellula, tessuto o organismo specifico, cercando di organizzare le informazioni in database e applicando i dati (come in medicina o biologia). La ricerca proteomica è lo studio sistematico su larga scala delle proteine. Poiché le proteine sono i mattoni fondamentali delle cellule, la ricerca proteomica cerca di rispondere a tutte le domande su di esse.
La ricerca sulla proteomica può trarre vantaggio dai progressi nella spettrometria di massa e nei database di sequenze di proteine e DNA. Per l'identificazione delle proteine, la determinazione quantitativa e il riconoscimento delle interazioni proteiche, la proteomica richiede un set diversificato di strumenti, macchinari, reagenti, supporti e software. Alcuni dei tipi più comuni di proteomica sono classificati come proteomica strutturale, proteomica di espressione e proteomica funzionale. La cristallografia a raggi X e la spettroscopia di risonanza magnetica nucleare sono due tecnologie utilizzate nella proteomica strutturale. Nella proteomica di espressione, vengono utilizzate tecnologie come 2D-PAGE e spettrometria di massa, mentre la cromatografia di affinità viene implementata per isolare i sub-proteomi.
| ATTRIBUTO | DETTAGLI |
| Periodo di studio | 2020-2029 |
| Anno base | 2021 |
| Anno stimato | 2022 |
| Anno previsto | 2022-2029 |
| Periodo storico | 2018-2020 |
| Unità | Valore (miliardi di USD) |
| Segmentazione | Per prodotto, per tecnologia, per applicazione, per utente finale, per regione |
| Con la tecnologia della resina |
|
| Per tecnologia |
|
| Per applicazione |
|
| Per utente finale |
|
| Per regione |
|
L'epidemia di COVID-19 ha ostacolato le operazioni nel settore sanitario globale. La malattia ha temporaneamente spinto diversi settori, tra cui parti del settore sanitario, a chiudere i battenti. La pandemia ha aumentato notevolmente la domanda di servizi di proteomica nel 2020, il che ha portato a una modesta crescita nel mercato mondiale della proteomica.
Inoltre, l'identificazione di proteine specifiche per il COVID-19 è stata resa possibile dall'applicazione di metodi di spettrometria di massa all'avanguardia. Tuttavia, si prevede che il mercato della proteomica crescerà costantemente nel 2021 e si espanderà a un CAGR considerevole per tutto il periodo di previsione. Ciò è spiegato dall'aumento dell'uso di medicinali su misura per il trattamento di malattie specifiche durante il COVID-19, nonché da un aumento dell'innovazione tecnologica nel campo della proteomica.
The Proteomics Market size had crossed USD 21.79 Billion in 2020 and will observe a CAGR of more than 15.15% up to 2029.
Major factors driving the proteomics market growth include the rise in the geriatric population demanding personalized medicines, growing demand for advanced diagnostics in targeted disease treatment, growing prevalence of target diseases, growing demand for therapeutic medicines, and outbreak of COVID-19.
Thermo Fisher Scientific Inc., Merck KGaA, Waters Corporation, GE Healthcare, Luminex Corporation, Bio-Rad Laboratories Inc, Agilent Technologies Inc., Li-Cor Inc, Bruker Corporation, Perkin Elmer Inc, Creative Proteomics, Promega Corporation, Sengenics, Danaher Corporation, Horiba Ltd. are the major Proteomics market players.
The region's largest share is in North America. Products manufactured in nations like US and Canada that perform similarly and are inexpensively accessible to the general public have led to the increasing appeal.
The proteomics market is segmented based on products, technology, application, end user, and region, global trends and forecast.
On the basis of products, the market is segmented into instruments, reagents & kits, core proteomics services.
The worldwide proteomics market is divided into services, reagents & kits, and instruments based on product. In 2021, more than 70% of global revenue came from the reagents and kits market. The segment is anticipated to increase at the fastest rate throughout the course of the projection period. This is because academic institutions, research labs, and other institutions frequently employ reagents, kits, chemicals, and strips for the inspection of diverse biological samples, which will enhance demand for reagents & kits and support sector growth. Proteomics market expansion would also be supported by technological developments in sophisticated tools, such as 2-d electrophoresis protein analyzers, that increase the productivity, throughput, and speed of biological research.
On the basis of technology, the market is segmented into microarray instruments, x-ray crystallography, spectroscopy, chromatography, protein fractionation systems, electrophoresis, surface plasma resonance systems.
The segment with the largest income share in 2021—more than 47.00%—was spectroscopy. During the forecast period, it is anticipated to increase at the fastest rate going forward. The widespread use of spectroscopy-based technologies in numerous analytical applications, such as drug development procedures, proteomics, metabolomics, forensic analysis, and pharmaceutical analysis, is one of the key reasons fueling the segment's expansion.
On the basis of application, the market is segmented into drug discovery, clinical diagnosis, cancer research.
In 2021, the clinical diagnostics segment held a share of more than 51.65%, dominating the market. This is explained by the widespread use of protein analysis in clinical research to find illness biomarkers for early disease identification and to pinpoint specific risk factors. It is anticipated that this would open up new avenues for illness prevention and early intervention. Proteomics-based diagnostics makes it feasible to find prospective biomarkers and protein expression patterns that might be used to identify, forecast, and assess the prognosis of malignancies, which supports the segment's expansion.
On the other hand, it is predicted that during the projected time, the drug discovery segment will increase at the fastest rate. The expansion of this market can be attributed to the development of structure-based drug design, increased emphasis on developing specially chosen, and increased funding in these fields. Proteomics technologies also provide a mechanism to demonstrate a medicine's potential early in the drug discovery process, saving pharmaceutical companies a large sum of money and ultimately helping patients and healthcare systems, which supports the segment's expansion.
On the basis of end user, the market is segmented into contract research organizations, research & academic institutes, pharma & biotech companies.
By the ending of 2023, the research and academic institutions sector is anticipated to have a bigger market share of around 51.5%. An increase in research and development activities, a diversity of ongoing proteome studies for the treatment of various life-threatening diseases, and an increase in life science projects in research and academic settings are all contributing to the increased demand for molecular biology, enzymes, reagents, and kits.
[caption id="attachment_15083" align="aligncenter" width="1920"]
Thermo Fisher Scientific Inc., Merck KGaA, Waters Corporation, GE Healthcare, Luminex Corporation, Bio-Rad Laboratories Inc, Agilent Technologies Inc., Li-Cor Inc, Bruker Corporation, Perkin Elmer Inc, Creative Proteomics, Promega Corporation, Sengenics, Danaher Corporation, Horiba Ltd. are the major Proteomics market players.
6 February, 2023: Thermo Fisher Scientific announced its collaboration with Celltrio to bring a fully automated cell system to biotherapeutics customers. Thermo Fisher will take on responsibility for sales, installation and support in Europe.
22 December, 2022: Merck announced a research collaboration and commercial license agreement with Mersana Therapeutics, Inc., to discover novel antibody-drug conjugates leveraging Mersana’s proprietary Immunosynthen STING-agonist ADC platform.
The Proteomics Market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
With a 45.90% revenue share in 2021, North America dominated the sector. The development of structure-based drug design, development of omics research, desire for high-quality research tools for data reproducibility, and focus on the creation of customized treatments are all attributed with this. Partnerships and cooperation among leading businesses in this area are also helping to expand this sector.
Due to increased outsourcing of proteomics-based projects, public and private funding for research and development for proteomics studies, advantageous government regulations, rising prevalence of target diseases with an older workforce, and rising proteomics adoption, the Asia Pacific region is predicted to grow at the fastest CAGR between 2022 and 2030. For instance, the Department of Biotechnology of the Indian tax payer funded 60 million dollars to the University of Hyderabad in November 2021 to study the tomato proteome. Such government initiatives to promote the proteomics study are driving the market in Asia Pacific.
[caption id="attachment_15090" align="aligncenter" width="1920"]
Want to know more about the report or any specific requirement?
We asked them to research ‘ Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
We asked them to research ‘Equipment market’ all over the world, and their whole arrangement was helpful to us. thehealthanalytics.com insightful analysis and reports contributed to our current analysis and in creating a future strategy. Besides, the te
Our Report’s database covers almost all topics of all regions over the Globe.
Tie ups with top publishers around the globe.
Complete pre and post sales support.
Complete secure payment process.